Stay updated on Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page
- CheckyesterdayChange DetectedThe study record history now includes a new revision tag, v3.6.6, and removes the previous v3.6.5 tag, updating the visible revision history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe revision history now includes the latest revision entry, v3.6.5, and drops the previous v3.6.4. This reflects an update to the page's revision metadata rather than any user-facing content change.SummaryDifference0.1%

- Check37 days agoChange DetectedThe history section now shows Revision: v3.6.4, replacing the previous v3.6.3. This denotes an update to the page's versioning rather than to study data.SummaryDifference0.1%

- Check58 days agoChange DetectedThe revision line was updated from v3.6.2 to v3.6.3, indicating a newer version of the page. This reflects an update to the page's revision history interface rather than changes to the study record data.SummaryDifference0.1%

- Check65 days agoChange DetectedA new revision tag v3.6.2 was added and the old v3.6.0 tag was removed on the page, indicating a small update to the revision history display.SummaryDifference0.1%

- Check79 days agoChange DetectedA new recruitment-status entry 'No longer looking for participants' was added. The revision was updated to v3.6.0, replacing the prior v3.5.5 entry.SummaryDifference0.3%

Stay in the know with updates to Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.